BN 80927: A novel homocamptothecin with inhibitory activities on both topoisomerase I and topoisomerase II

Bioorganic & Medicinal Chemistry Letters
1999.0

Abstract

BN 80927, a novel homocamptothecin derivative, inhibits both topoisomerase I and topoisomerase II mediated DNA relaxation and shows pronounced cytotoxicity against HT29, SKOV-3, DU145 and MCF7 human tumor cell lines.

Knowledge Graph

Similar Paper

BN 80927: A novel homocamptothecin with inhibitory activities on both topoisomerase I and topoisomerase II
Bioorganic & Medicinal Chemistry Letters 1999.0
BN 80245: An E-ring modified camptothecin with potent antiproliferative and topoisomerase I inhibitory activities
Bioorganic & Medicinal Chemistry Letters 1997.0
Phosphate ester derivatives of homocamptothecin: Synthesis, solution stabilities and antitumor activities
Bioorganic & Medicinal Chemistry 2010.0
Design, synthesis and biological evaluation of novel homocamptothecin analogues as potent antitumor agents
Bioorganic & Medicinal Chemistry 2015.0
Synthesis and biological evaluation of novel 7-acyl homocamptothecins as Topoisomerase I inhibitors
European Journal of Medicinal Chemistry 2011.0
Camptothecin and Minor-Groove Binder Hybrid Molecules:  Synthesis, Inhibition of Topoisomerase I, and Anticancer Cytotoxicity in Vitro
Journal of Medicinal Chemistry 1997.0
Homocamptothecins:  Synthesis and Antitumor Activity of Novel E-Ring-Modified Camptothecin Analogues
Journal of Medicinal Chemistry 1998.0
Novel water-solutle (7-(acylhydrazono)-formyl camptothecins as potent inhibitors of DNA topoisomerase I
Bioorganic & Medicinal Chemistry Letters 1994.0
Design, synthesis and antitumor activity of non-camptothecin topoisomerase I inhibitors
Bioorganic & Medicinal Chemistry Letters 2015.0
Synthesis and biological evaluation of new homocamptothecin analogs
European Journal of Medicinal Chemistry 2012.0